Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G FORNI

Showing results (241-250 of 326) with videos related to

Pageof 33
Sort By:
Cell|July 10, 1992
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transductionG Pelicci, L Lanfrancone, F Grignani, et al.
Tumori|April 30, 1988
Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable propertiesA Molino, G Stevanoni, P Lorenzi, et al.
Intensive Care Medicine|May 4, 2017
Renal recovery after acute kidney injuryL G Forni, M Darmon, M Ostermann, et al.
European Journal of Immunology|May 1, 1995
Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory responseF Cavallo, A Martin-Fontecha, M Bellone, et al.
British Journal of Haematology|May 1, 1990
Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid originR Foa, P Caretto, M T Fierro, et al.
European Journal of Immunology|August 1, 1996
Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumorsA Martin-Fontecha, F Cavallo, M Bellone, et al.
Acta Oto-Laryngologica|January 1, 1991
The effect of preoperative local interleukin-2 (IL-2) injections in patients with head and neck squamous cell carcinoma. An immunological studyG Cortesina, A De Stefani, E Galeazzi, et al.
Journal of Biological Response Modifiers|December 1, 1989
Effect of low doses of interleukin-2 injected perilymphatically and peritumorally in patients with advanced primary head and neck squamous cell carcinomaP Musiani, E De Campora, S Valitutti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1993
Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophagesM C Bosco, T Musso, G L Gusella, et al.
British Journal of Cancer|November 1, 1996
Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cellsP Nanni, C De Giovanni, L Landuzzi, et al.
Pageof 33

Showing results (241-250 of 326) with videos related to

Sort By:
Pageof 33
Cell|July 10, 1992
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transductionG Pelicci, L Lanfrancone, F Grignani, et al.
Tumori|April 30, 1988
Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable propertiesA Molino, G Stevanoni, P Lorenzi, et al.
Intensive Care Medicine|May 4, 2017
Renal recovery after acute kidney injuryL G Forni, M Darmon, M Ostermann, et al.
European Journal of Immunology|May 1, 1995
Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory responseF Cavallo, A Martin-Fontecha, M Bellone, et al.
British Journal of Haematology|May 1, 1990
Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid originR Foa, P Caretto, M T Fierro, et al.
European Journal of Immunology|August 1, 1996
Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumorsA Martin-Fontecha, F Cavallo, M Bellone, et al.
Acta Oto-Laryngologica|January 1, 1991
The effect of preoperative local interleukin-2 (IL-2) injections in patients with head and neck squamous cell carcinoma. An immunological studyG Cortesina, A De Stefani, E Galeazzi, et al.
Journal of Biological Response Modifiers|December 1, 1989
Effect of low doses of interleukin-2 injected perilymphatically and peritumorally in patients with advanced primary head and neck squamous cell carcinomaP Musiani, E De Campora, S Valitutti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1993
Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophagesM C Bosco, T Musso, G L Gusella, et al.
British Journal of Cancer|November 1, 1996
Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cellsP Nanni, C De Giovanni, L Landuzzi, et al.
Pageof 33